🚀 Key Features of the NeuEra Series PET/CT
The NeuroQ™ program is used to regionally quantify activity in brain PET scans using a ROI count method. It displays co-registered PET and CT images, along with output from quantification of activities reflecting regional concentrations of FDG, amyloid imaging agents, and dopamine transporter radiotracers, relative to activities in any of several user-selected reference regions or whole brain. It provides for displaying and quantifying the regional differences between two PET brain studies for the same patient, or the levels of amyloid imaging agents retained in specified brain regions of a patient, and for assisting the user in the examination of brain scans acquired for assessing differential diagnosis of neurodegenerative processes underlying symptoms of cognitive and movement disorders by comparing regional activity values to each other and to those in brain scans acquired for asymptomatic control subjects. These neurodegenerative processes can be Alzheimer’s disease, Lewy body dementia,
#Parkinson's disease with dementia, vascular dementia, and frontotemporal dementia.
#NeusoftMedical
#InnovatingforYou
#PETCT